Original Study| Volume 31, ISSUE 3, P258-262, June 2018

Download started.


Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents?

Published:December 09, 2017DOI:


      Study Objective

      Although early diagnosis of polycystic ovary syndrome (PCOS) in adolescents might allow for earlier treatment and prevention of chronic disorders, incorrect or premature diagnosis carries risks of unnecessary treatment and psychological distress. There is no consensus concerning which diagnostic criteria to use for adolescents and current criteria vary. The objective of this study was to determine whether using different diagnostic criteria will affect PCOS diagnosis in adolescents.

      Design, Setting, and Participants

      Fifty-two patients aged 13-18 years with at least 2 of the following criteria were included in the study: (1) oligomenorrhea or amenorrhea; (2) Clinical or biochemical hyperandrogenism; and (3) polycystic ovaries on ultrasonography. Patients were then categorized according to the 6 different criteria for PCOS. National Institutes of Health, Rotterdam criteria, Androgen Excess Society, Amsterdam criteria, Endocrine Society criteria, and the Pediatric Endocrine Society criteria. The characteristics of adolescents who were diagnosed with PCOS were also evaluated.

      Interventions and Main Outcome Measures

      Forty-one patients out of 52 (78.8%) received diagnosis with National Institutes of Health and Endocrine Society criteria, all with Rotterdam criteria, 45/52 (86.5%) with Androgen Excess Society criteria, 36/52 (69.2%) with Amsterdam criteria and 34/52 (65.4%) with the Pediatric Endocrine Society criteria.

      Results and Conclusion

      This study shows that the choice of guideline used does have a great effect on whether an adolescent received the PCOS diagnosis or not. For physicians using the broader criteria, care should be taken to ensure the patient does not receive diagnosis because of the physiological changes seen during puberty, which might mimic PCOS. For those using stricter criteria, close monitoring of patients who do not receive diagnosis is necessary to prevent chronic complications.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Baldauff N.H.
        • Witchel S.F.
        Polycystic ovary syndrome in adolescent girls.
        Curr Opin Endocrinol Diabetes Obes. 2017; 24: 56
        • Zawadzki J.
        • Dunaif A.
        Diagnostic criteria for polycystic ovary syndrome: towards a rational approach.
        in: Polycystic Ovary Syndrome. Blackwell Scientific, Boston1992: 377-384
        • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
        Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
        Fertil Steril. 2004; 81: 19
        • Azziz R.
        • Carmina E.
        • Dewailly D.
        • et al.
        Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline.
        J Clin Endocrinol Metab. 2006; 91: 4237
        • Rosenfield R.L.
        The diagnosis of polycystic ovary syndrome in adolescents.
        Pediatrics. 2015; 136: 1154
        • Carmina E.
        • Oberfield S.E.
        • Lobo R.A.
        The diagnosis of polycystic ovary syndrome in adolescents.
        Am J Obstet Gynecol. 2010; 203: 201.e1
      1. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS).
        Hum Reprod. 2012; 27: 14
        • Legro R.S.
        • Arslanian S.A.
        • Ehrmann D.A.
        • et al.
        Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
        J Clin Endocrinol Metab. 2013; 98: 4565
        • Witchel S.F.
        • Oberfield S.
        • Rosenfield R.L.
        • et al.
        The diagnosis of polycystic ovary syndrome during adolescence.
        Horm Res Paediatr. 2015; 83: 376
        • Chang R.J.
        • Coffler M.S.
        Polycystic ovary syndrome: early detection in the adolescent.
        Clin Obstet Gynecol. 2007; 50: 178
        • Ferriman D.
        • Gallwey J.
        Clinical assessment of body hair growth in women.
        J Clin Endocrinol Metab. 1961; 21: 1440
        • Marshall W.A.
        • Tanner J.M.
        Variations in pattern of pubertal changes in girls.
        Arch Dis Child. 1969; 44: 291
        • Bundak R.
        • Furman A.
        • Gunoz H.
        • et al.
        Body mass index references for Turkish children.
        Acta Paediatr. 2006; 95: 194
        • Blank S.K.
        • Helm K.D.
        • McCartney C.R.
        • et al.
        Polycystic ovary syndrome in adolescence.
        Ann N Y Acad Sci. 2008; 1135: 76
        • Sıklar Z.
        • Berberoğlu M.
        • Çamtosun E.
        • et al.
        Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence.
        J Pediatr Adolesc Gynecol. 2015; 28: 78
        • Metcalf M.
        • Skidmore D.
        • Lowry G.
        • et al.
        Incidence of ovulation in the years after the menarche.
        J Endocrinol. 1983; 97: 213
        • Olutunmbi Y.
        • Paley K.
        • English J.C.
        Adolescent female acne: etiology and management.
        J Pediatr Adolesc Gynecol. 2008; 21: 171
        • Biro F.M.
        • Emans S.J.
        Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls.
        J Adolesc Health. 2008; 43: 103
        • Rosner W.
        • Auchus R.J.
        • Azziz R.
        • et al.
        Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.
        J Clin Endocrinol Metab. 2007; 92: 405
        • Mortensen M.
        • Rosenfield R.L.
        • Littlejohn E.
        Functional significance of polycystic-size ovaries in healthy adolescents.
        J Clin Endocrinol Metab. 2006; 91: 3786
        • Coviello A.D.
        • Legro R.S.
        • Dunaif A.
        Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
        J Clin Endocrinol Metab. 2006; 91: 492
        • Kerchner A.
        • Lester W.
        • Stuart S.P.
        • et al.
        Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study.
        Fertil Steril. 2009; 91: 207
        • Rosenfield R.L.
        • Ehrmann D.A.
        The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited.
        Endocr Rev. 2016; 37: 467
        • Roe A.H.
        • Prochaska E.
        • Smith M.
        • et al.
        Using the Androgen Excess–PCOS Society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents.
        J Pediatr. 2013; 162: 937
        • Hickey M.
        • Doherty D.
        • Atkinson H.
        • et al.
        Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis.
        Hum Reprod. 2011; 26: 1469
        • Agapova S.E.
        • Cameo T.
        • Sopher A.B.
        • et al.
        Diagnosis and challenges of polycystic ovary syndrome in adolescence.
        Semin Reprod Med. 2014; 32: 194
        • Merino P.M.
        • Codner E.
        • Cassorla F.
        A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence.
        Arq Bras Endocrinol Metabol. 2011; 55: 590
        • Moran L.J.
        • Misso M.L.
        • Wild R.A.
        • et al.
        Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
        Hum Reprod Update. 2010; 16: 347
        • Nicandri K.F.
        • Hoeger K.
        Diagnosis and treatment of polycystic ovarian syndrome in adolescents.
        Curr Opin Endocrinol Diabetes Obes. 2012; 19: 497
        • Flannery C.A.
        • Rackow B.
        • Cong X.
        • et al.
        Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.
        Pediatr Diabetes. 2013; 14: 42
        • Sultan C.
        • Paris F.
        Clinical expression of polycystic ovary syndrome in adolescent girls.
        Fertil Steril. 2006; 86: S6
        • Auble B.
        • Elder D.
        • Gross A.
        • et al.
        Differences in the management of adolescents with polycystic ovary syndrome across pediatric specialties.
        J Pediatr Adolesc Gynecol. 2013; 26: 234
        • Powers S.E.
        • Uliassi N.W.
        • Sullivan S.D.
        • et al.
        Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome.
        J Pediatr Adolesc Gynecol. 2015; 28: 43